Beijing Chunlizhengda Medical Instruments Co., Ltd. (SHA:688236)
16.76
-0.14 (-0.83%)
Jun 6, 2025, 2:45 PM CST
SHA:688236 Revenue
Beijing Chunlizhengda Medical Instruments had revenue of 229.84M CNY in the quarter ending March 31, 2025, with 3.60% growth. This brings the company's revenue in the last twelve months to 813.85M, down -31.26% year-over-year. In the year 2024, Beijing Chunlizhengda Medical Instruments had annual revenue of 805.86M, down -33.32%.
Revenue (ttm)
813.85M
Revenue Growth
-31.26%
P/S Ratio
7.11
Revenue / Employee
657.92K
Employees
1,237
Market Cap
5.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 805.86M | -402.67M | -33.32% |
Dec 31, 2023 | 1.21B | 6.92M | 0.58% |
Dec 31, 2022 | 1.20B | 93.46M | 8.43% |
Dec 31, 2021 | 1.11B | 170.45M | 18.18% |
Dec 31, 2020 | 937.69M | 82.36M | 9.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |